Delivery Order SPE2DB22D7058-SPE2DB25FSUR9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,266.23 fixed-price delivery order is for the supply of 4,568,160,675 units of the medication Valsartan-HCTZ 320-25 mg tablets. The contract has an ultimate completion date of May 7, 2025 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen holds a $999,999,999.00...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,424.29, is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,462.85 firm fixed-price delivery order is for the supply of 4,564,404,281 units of the medication Valsartan-HCTZ 160-12.5 mg tablets. The contract has an ultimate completion date of April 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,154,096 units of the drug Valsartan-HCTZ 160-12.5 mg tablets. The firm-fixed-price delivery order contract has a ceiling value of $4,156.30 and a completion date of December 21, 2023. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,894.05 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,062,501 units of Valsartan-HCTZ 320-12.5 mg tablets. The contract has an ultimate completion date of January 29, 2025. This contract is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,887.52 contract is for the supply of 4,568,092,529 units of the medication Valsartan-HCTZ 320-25 mg tablets. The award is not set aside and has an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,337.78, is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of January 27, 2025 and is a firm-fixed-price type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,351.98, is for the delivery of Valsartan-HCTZ 320-25 mg tablets. It is a firm-fixed price delivery order contract with an ultimate completion date of April 2, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award, valued at $4,870.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract has a completion date of March 11, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets, valued at $2,816.28. It is a firm fixed-price delivery order with an ultimate completion date of April 8, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
- SPE2DB22D7058Indefinite Delivery Contract
- SPE2DB22D7058-SPE2DB25FSUR9Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,581.62, is for the delivery of 4,567,223,373 units of the medication Valsartan-HCTZ 80-12.5 mg tablets in 90-count bottles. The contract is a firm fixed-price delivery order with a completion date of February 12, 2025. This award is not associated with a set-aside and appears to be an open competition contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 2/11/25 |